After the postponement of the first lawsuit selected for a bellwether trial, a new case has been scheduled to kick off the trials. The first trial will now involve a lawsuit filed by an Alabama man who developed liver cancer after taking Valsartan. This case is seen as a stronger choice, as it will provide valuable insights to all plaintiffs—and potential plaintiffs—about what they can expect as the litigation progresses.

[fluentform id=”15″]